West Pharmaceutical Services Inc. (NYSE:WST) went down by -1.04% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Medical Instruments & Supplies giant went up by $220.13 to trade ended Monday trading at $222.45. This is down from the $222.45 price recorded on Friday’s trading session. Thanks to this latest performance, WST is closer to the higher price 52-week target of $200.00 and further from the lowest price target of $185.00. Its performance from the start of the year has also been positive, with WST up by 46.43% year-to-date.
West Pharmaceutical Services Inc. (WST) started the day trading at $223.08 and recorded an intraday high of $225.9. It also recorded an intraday low of $216.51 during Monday’s trading session. West Pharmaceutical Services Inc. is a very active stock that recorded a trading volume that is less than -39.59% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 615475, which is less than -39.59 of the total average daily trading volume of 859.14K.
West Pharmaceutical Services Inc. (NYSE:WST) 2020 Performance Impressive
The increase in WST’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of WST currently stands at $226.67, which is higher than the current trading price of the stock by 2.89%. However, WST’s current trading price is -83.26% lower than the 52-week low price of $120.12. In terms of trading volume, West Pharmaceutical Services Inc. currently experienced healthy participation during the last trading session. 615475 shares of West Pharmaceutical Services Inc. were traded on the stock exchange on Monday, which is less than -39.59% of the 859.14K average trading volume of the stock.
The performance of the stock has been positive over the past year. WST’s performance over the past one year has seen it surge by 75.89%, while the stock has gone up by 45.97% in the last six months. The quarterly performance of WST currently stands at 45.00%, and it is up by 1.89% in the last month. The only positive figure was from the weekly performance, which currently reads 1.07%. At the time of writing WST’s report, the company has a total market cap of $16.27B, making it one of the largest publicly-traded companies in the world.West Pharmaceutical Services Inc. also has over 8200 employees all over the world.
WST Insider Activities
For West Pharmaceutical Services Inc., insiders hold 93.40% of all company shares. The insider transactions over the past six months are up by 6.40%. During that period, insiders bought 43,576 shares in 25 transactions. In that same period, insiders sold 25,806 of their shares in 14 transactions. After these transactions, insiders at West Pharmaceutical Services Inc. now hold 414.38k shares, which is over 95.18% of the total company stocks. Institutional investors currently hold a large chunk of the WST shares, as they control 0.56% of the company’s total stock.
WST Fundamental Analysis
For West Pharmaceutical Services Inc., the stock’s diluted earnings per share (EPS) stands at 3.45. In the coming year, analysts expect the EPS to be 4.06. The EPS growth will up over the next five years to 8.90% after surging by 12.90% in the previous five years. In terms of revenue, West Pharmaceutical Services Inc.’s quarterly sales (YOY) is growing at 0.88, which is lower than the average annual revenue of 12.90% over the past half a decade.
The Return on Investment (ROI) on West Pharmaceutical Services Inc.’s stock currently stands at 13.00%, and it has a net profit margin of 13.80%. The operating margin of the company is 16.60%, and its gross margin is 33.20%.
WST Analysts Prediction
In April 24, 2020, several analysts reiterated their positions on the West Pharmaceutical Services Inc. stock and predicted its performance to their investors. The analysts at BofA/Merrill believe WST is still a Neutral and set the price target between $145 and $200.
At the moment, West Pharmaceutical Services Inc.’s Total Debt to Equity ratio stands at 0.17, and they have a long-term Debt to Equity ratio of 0.17.
WST Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of WST currently stands at 4.00%, while the SMA50 is 8.25%. The biggest one is the SMA200, which is currently reading 34.82% ahead of Monday’s trading session. The Relative Strength Index of this stock is 61.76, while its price to earnings ratio (P/E) is 63.73.